MétaCan
Menu
Back to cohort
Record W2346446766 · doi:10.1097/qad.0000000000001141

Preexposure prophylaxis on-demand dramatically reduces HIV incidence in MSM

2016· letter· en· W2346446766 on OpenAlexaboutno aff
Kristin N. Harper

Bibliographic record

VenueAIDS · 2016
Typeletter
Languageen
FieldMedicine
TopicHIV/AIDS Research and Interventions
Canadian institutionsnot available
Fundersnot available
KeywordsPillPre-exposure prophylaxisMedicineHuman immunodeficiency virus (HIV)Men who have sex with menClinical trialIncidence (geometry)Family medicineRandomized controlled trialFlexibility (engineering)DemographyGynecologyInternal medicinePharmacology

Abstract

fetched live from OpenAlex

Recently, multiple clinical trials have shown that preexposure prophylaxis (PrEP) is an effective means of preventing HIV infection – but only if individuals adhere to the treatment, which involves a daily dose of drugs. In a recent issue of the New England Journal of Medicine (2015; 373: 2237–2246), Jean-Michel Molina of the Hôpital Saint-Louis and colleagues reported the results of IPERGAY, a randomized controlled trial that assessed a different PrEP dosage system: two pills 2–24 h before sex, a third pill 24 h after the first pill, and a fourth pill 24 h after that. In MSM, the group being studied, this treatment was associated with an 86% reduction in new HIV infections, one of the largest reported to date for PrEP. Jared Baeten of the University of Washington comments, ‘While the Molina et al. results are just one study, they are pretty powerful and are backed up by animal model data that suggested an on-demand approach would work in the first place.’ Cécile Tremblay of the Université de Montréal observes, ‘We have already seen an effect of the IPERGAY results on PrEP uptake. These results validated the efficacy of PrEP and increased confidence in both patients and doctors that the approach was effective. On-demand PrEP gives more flexibility and options to patients.’ Molina explains that in some countries, such as France, both daily and on-demand PrEP regimens have already been approved for MSM, and the European AIDS Clinical Society guidelines for PrEP include both the options. On-demand dosing is proving popular in some places: Tremblay notes that in Montreal, 20–30% of patients on PrEP now take it on-demand. Robert Grant of the University of California, San Francisco, observes, ‘on-demand dosing will be best suited for people who plan and schedule sexual activity,’ though he adds, ‘I doubt there will be much influence (of the study) in the United States, where both the FDA and the CDC recommend daily use of PrEP.’ He also emphasizes that on-demand dosing is unproven for women and trans men exposed to HIV by vaginal intercourse. Baetan concludes, ‘People want and need options for protecting themselves from HIV, and an on-demand strategy might work for some, while others will prefer a more fixed routine. As a scientist, prescriber, and policymaker, I think we have to do our best to give people effective options that they can use.’ Acknowledgements Conflicts of interest There are no conflicts of interest.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesInsufficient payload (model declined to judge)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: none
Teacher disagreement score0.644
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.312
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueAIDSSame topicHIV/AIDS Research and InterventionsFrench-language works237,207